Botox 100 unit vials
Ended Awarded
- Contract number
- SPE2DB26FSU72
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,251
Award facts
- Contract value 100% obligated
- $9,251.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $9,251.40 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of BOTOX 100 Unit Vials. The delivery order, issued on October 21, 2025, with an ultimate completion date of November 12, 2025, carries no set-aside designation, indicating DMS Pharmaceutical Group's competitive capability in unrestricted federal procurement. This award represents a discrete transaction under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to ensure consistent pharmaceutical supply to Department of Defense medical facilities.
DMS Pharmaceutical Group serves as a critical supplier within the Defense Logistics Agency's Medical Supply Chain division, leveraging its single-award indefinite delivery contract (SPE2DR) valued at $499,999,999 and extending through December 31, 2036. The company's established performance across numerous delivery orders spanning oncology treatments, biologics, vaccines, and specialty pharmaceuticals demonstrates its capability to fulfill diverse pharmaceutical requirements across the federal military medical system. As a woman-owned small business registered in the System for Award Management since 2001, DMS Pharmaceutical Group operates without identified subcontractors and maintains consistent contract performance across multiple therapeutic categories supporting worldwide Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DB26FSU72?
SPE2DB26FSU72 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 21, 2025.
How much is contract SPE2DB26FSU72 worth?
The government has obligated $9,251 on SPE2DB26FSU72.
Is contract SPE2DB26FSU72 an order under another contract?
Yes. SPE2DB26FSU72 is a delivery order under SPE2DB22D9367, an indefinite delivery contract.
Was contract SPE2DB26FSU72 competed?
The extent of competition for SPE2DB26FSU72 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award